Venous Thromboembolism Issues in Women

zu Verbundenen Objekten

Abstract: The lifetime risk of venous thromboembolism (VTE) is slightly higher in women than in men. There are several issues related to VTE that are unique to women. Combined hormonal contraceptives and pregnancy increase the risk of VTE in women of childbearing age, whereas hormone replacement therapy increases the VTE risk of postmenopausal women. Hereditary thrombophilia and risk factors such as older age, obesity, or smoking contribute to the risk increase. In women diagnosed with acute hormone-related VTE who are treated with oral anticoagulants, adequate contraception is mandatory to avoid unwanted pregnancies. According to current knowledge, hormonal contraception may be continued during anticoagulant therapy but must be switched to an estrogen-free contraception method at least 6 weeks before the termination of anticoagulation. VTE is also a major cause of maternal morbidity and mortality during pregnancy and the postpartum period. Currently, assisted reproduction technologies such as in vitro fertilization are widely used to treat couples affected by infertility. Complications of fertility treatment comprise VTE cases, especially in women with ovarian hyperstimulation syndrome. With this review, we intended to focus on VTE issues in women and summarize current evidence and guideline recommendations.

Standort
Deutsche Nationalbibliothek Frankfurt am Main
Umfang
Online-Ressource
Sprache
Englisch

Erschienen in
Venous Thromboembolism Issues in Women ; volume:42 ; number:05 ; year:2022 ; pages:290-299
Hämostaseologie ; 42, Heft 05 (2022), 290-299

Beteiligte Personen und Organisationen
Linnemann, Birgit
Rott, Hannelore
Zotz, Rainer
Hart, Christina

DOI
10.1055/a-1919-9558
URN
urn:nbn:de:101:1-2022122210313659234636
Rechteinformation
Kein Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Letzte Aktualisierung
15.08.2025, 07:32 MESZ

Datenpartner

Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Original beim Datenpartner anzeigen

Beteiligte

  • Linnemann, Birgit
  • Rott, Hannelore
  • Zotz, Rainer
  • Hart, Christina

Ähnliche Objekte (12)

Venous Thromboembolism in COVID-19: Are Women Different?

Venous Thromboembolism in COVID-19: Are Women Different?

Venous anomalies and thromboembolism

Venous anomalies and thromboembolism

Venous Thromboembolism in COVID-19

Venous Thromboembolism in COVID-19

Circumstances of provoked recurrent venous thromboembolism: the Austrian study on recurrent venous thromboembolism

Circumstances of provoked recurrent venous thromboembolism: the Austrian study on recurrent venous thromboembolism

Venous thromboembolism : prevention and treatment

Konferenzschrift | Kongress

Venous thromboembolism : prevention and treatment

Heparin and Venous Thrombo-Embolism

Heparin and Venous Thrombo-Embolism

Venous thromboembolism and cancer risk

Venous thromboembolism and cancer risk

Predicting Venous Thromboembolism in Primary Care

Predicting Venous Thromboembolism in Primary Care

Management of venous thromboembolism: an update

Management of venous thromboembolism: an update

Aspirin for prophylaxis of venous thromboembolism

Aspirin for prophylaxis of venous thromboembolism

Letter to the Editor: Venous Thromboembolism in COVID-19: Are Women Different?

Letter to the Editor: Venous Thromboembolism in COVID-19: Are Women Different?

Family history of venous thromboembolism and mortality after venous thromboembolism: a Swedish population-based cohort study

Family history of venous thromboembolism and mortality after venous thromboembolism: a Swedish population-based cohort study

Verbundene Objekte